(S (NP (NP (JJ Pancreatic) (NN ductal) (NN adenocarcinoma)) (PRN (-LRB- -LRB-) (NP (NNP PDAC)) (-RRB- -RRB-))) (VP (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (JJ lethal)) (NNS cancers))))) (CC and) (VP (VBZ carries) (NP (DT a) (JJ dismal) (NN prognosis)))) (. .))
(S (NP (NN Surgery)) (VP (VBZ remains) (NP (DT the) (JJS best) (NN chance)) (PP (IN of) (NP (DT a) (JJ potential) (NN cure))) (PP (IN for) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADJP (JJ eligible) (PP (IN for) (NP (NP (JJ initial) (NN resection)) (PP (IN of) (NP (NNP PDAC)))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NNS outcomes)) (VP (VBP vary) (ADVP (RB significantly)) (PP (ADVP (RB even)) (IN among) (NP (NP (NP (DT the) (JJ resected) (NNS patients)) (PP (IN of) (NP (DT the) (JJ same) (NN stage)))) (CC and) (VP (VBD received) (NP (JJ similar) (NNS treatments)))))) (. .))
(S (NP (NP (NNP Accurate) (JJ preoperative) (NN prognosis)) (PP (IN of) (NP (JJ resectable) (NNP PDACs))) (PP (IN for) (NP (JJ personalized) (NN treatment)))) (VP (VBZ is) (ADVP (RB thus)) (VP (ADVP (RB highly)) (VBN desired))) (. .))
(S (ADVP (RB Nevertheless)) (, ,) (NP (EX there)) (VP (VBP are) (NP (DT no) (JJ automated) (NNS methods)) (ADVP (RB yet)) (SBAR (S (VP (TO to) (VP (ADVP (RB fully)) (VB exploit) (NP (DT the) (JJ contrast-enhanced) (JJ computed) (NN tomography) (PRN (-LRB- -LRB-) (NP (NNP CE-CT)) (-RRB- -RRB-)) (VBG imaging)) (PP (IN for) (NP (NNP PDAC)))))))) (. .))
(S (NP (NP (NNP Tumor) (NN attenuation) (NNS changes)) (PP (IN across) (NP (JJ different) (NNP CT) (NNS phases)))) (VP (MD can) (VP (VB reflect) (NP (NP (NP (DT the) (NN tumor) (JJ internal) (JJ stromal) (NNS fractions)) (CC and) (NP (NP (NN vascularization)) (PP (IN of) (NP (JJ individual) (NNS tumors))))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB impact) (NP (DT the) (JJ clinical) (NNS outcomes))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (JJ deep) (JJ neural) (NN network)) (PP (IN for) (NP (NP (DT the) (JJ survival) (NN prediction)) (PP (IN of) (NP (JJ resectable) (NNP PDAC) (NNS patients))))) (, ,) (VP (VBN named) (PP (IN as) (NP (NP (CD 3D) (JJ Contrast-Enhanced) (NNP Convolutional) (NNP Long) (NNP Short-Term) (NNP Memory) (NN network)) (PRN (-LRB- -LRB-) (NP (NNP CE-ConvLSTM)) (-RRB- -RRB-))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB derive) (NP (DT the) (NN tumor) (NN attenuation) (VBZ signatures) (CC or) (NNS patterns)) (PP (IN from) (NP (NNP CE-CT) (VBG imaging) (NNS studies))))))))) (. .))
(S (NP (PRP We)) (VP (VBP present) (NP (NP (DT a) (JJ multi-task) (NNP CNN)) (SBAR (S (VP (TO to) (VP (VB accomplish) (NP (NP (DT both) (NNS tasks)) (PP (IN of) (NP (NN outcome) (CC and) (NN margin) (NN prediction)))) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN network)) (VP (NNS benefits) (PP (IN from) (S (VP (VBG learning) (NP (DT the) (NN tumor) (NN resection) (ADJP (NN margin) (VBN related)) (NNS features)) (S (VP (TO to) (VP (VB improve) (NP (NN survival) (NN prediction))))))))))))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN framework)) (VP (MD can) (VP (VB improve) (NP (DT the) (NN prediction) (NNS performances)) (PP (VBN compared) (PP (IN with) (NP (VBG existing) (JJ state-of-the-art) (JJ survival) (NN analysis) (NNS approaches)))))) (. .))
(S (NP (NP (DT The) (NN tumor) (NN signature)) (VP (VBN built) (PP (IN from) (NP (PRP$ our) (NN model))))) (VP (VBZ has) (ADVP (RB evidently)) (VP (VBN added) (NP (NP (NNS values)) (SBAR (S (VP (TO to) (VP (VB be) (VP (VBN combined) (PP (IN with) (NP (DT the) (VBG existing) (JJ clinical) (NN staging) (NN system))))))))))) (. .))
